ESRP1 and melanoma: showed that ESRP1 in melanoma significantly inhibits the growth of tamoxifen-resistant cells by affecting kinases that regulate mitosis (56, 80), the cell cycle, and cell proliferation, thereby altering epithelial-mesenchymal transition protein markers (4).